GSK-3 Inhibition Is Cytotoxic in Glioma Stem Cells through Centrosome Destabilization and Enhances the Effect of Radiotherapy in Orthotopic Models.
Anke Brüning-RichardsonGary C ShawDaniel TamsTim BrendHitesh SanganeeSimon T BarryGregory HammRichard J A GoodwinJohn G SwalesHenry KingLynette SteeleRuth MortonAnastasia WidyadariThomas A WardFilomena EstevesMarjorie BoissinotAlastair DroopSean E LawlerSusan C ShortPublished in: Cancers (2021)
These data suggest that GSK-3 inhibition promotes cell death in glioma through disrupting centrosome function and promoting mitotic failure and that AZD2858 is an effective adjuvant to radiation at clinical doses.